2022
DOI: 10.3390/biom12121807
|View full text |Cite
|
Sign up to set email alerts
|

Leucosceptosides A and B: Two Phenyl-Ethanoid Glycosides with Important Occurrence and Biological Activities

Abstract: In this review paper, the occurrence in the plant kingdom, the chemophenetic value and the biological activities associated with two specific phenyl-ethanoid glycosides, i.e., leucosceptoside A and leucosceptoside B, were reported. This is the first work ever conducted on such a subject. Analysis of the literature data clearly led to three important conclusions: leucosceptoside A is much more common in plants than leucosceptoside B; leucosceptoside A exerts more biological activities than leucosceptoside B eve… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 158 publications
0
1
0
Order By: Relevance
“…It is derived from the base compound verbascoside and is distinguished by a methyl group in its caffeic acid moiety. It exhibits unique structural features and notable biological activities [ 125 ], including therapeutic potential against psoriasis. In an in vitro model using IFN-γ/IL-17A/IL-22-stimulated HaCaT cells, leucosceptoside A effectively mitigated psoriasis-related inflammation by suppressing the PI3K/AKT signaling pathway.…”
Section: Natural Product-derived Compounds For Psoriasis Therapeuticsmentioning
confidence: 99%
“…It is derived from the base compound verbascoside and is distinguished by a methyl group in its caffeic acid moiety. It exhibits unique structural features and notable biological activities [ 125 ], including therapeutic potential against psoriasis. In an in vitro model using IFN-γ/IL-17A/IL-22-stimulated HaCaT cells, leucosceptoside A effectively mitigated psoriasis-related inflammation by suppressing the PI3K/AKT signaling pathway.…”
Section: Natural Product-derived Compounds For Psoriasis Therapeuticsmentioning
confidence: 99%